GKNM Hospital, Coimbatore, India Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2008
NCT00680940
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Radiation Oncologist, V. N. Cancer Centre, GKNM Hospital, Coimbatore, India | V.N. Cancer Center GKNM Hospital | V. N. Cancer Centre, GKNM Hospital, Coimbatore, India

Active Ingredients

Drugs in Phase 2 Trials (4)

cisplatin (platinol) (1 trial)

immuvac (1 trial)

paclitaxel (taxol) (1 trial)

riviciclib (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Lung Neoplasms (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4